Neil Graham's most recent trade in Zura Bio Ltd - Ordinary Shares - Class A was a trade of 117,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Zura Bio Ltd - Ordinary Sh... | Neil Graham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
Allakos Inc | Neil Graham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 41,000 | 41,000 | - | - | Stock Option (Right to buy) | |
Allakos Inc | Neil Graham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 154,786 | 154,786 | - | - | Stock Option (Right to buy) | |
Zura Bio Ltd - Ordinary Sh... | Neil Graham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 7,652 | 7,652 | - | - | Employee Share Option (Right to Buy) | |
Evelo Biosciences Inc | Neil Graham | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |